SBI Life Insurance Company Ltd
NSE:SBILIFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SBI Life Insurance Company Ltd
Total Equity
SBI Life Insurance Company Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
SBI Life Insurance Company Ltd
NSE:SBILIFE
|
Total Equity
₹183B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Star Health and Allied Insurance Company Ltd
NSE:STARHEALTH
|
Total Equity
₹71.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
ICICI Prudential Life Insurance Company Ltd
NSE:ICICIPRULI
|
Total Equity
₹136.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
HDFC Life Insurance Company Ltd
NSE:HDFCLIFE
|
Total Equity
₹177.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Max Financial Services Ltd
NSE:MFSL
|
Total Equity
₹53B
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Life Insurance Corporation Of India
NSE:LICI
|
Total Equity
₹1.3T
|
CAGR 3-Years
124%
|
CAGR 5-Years
163%
|
CAGR 10-Years
N/A
|
|
SBI Life Insurance Company Ltd
Glance View
SBI Life Insurance Company Ltd., a joint venture between State Bank of India, the country's most prominent banking institution, and the French financial group BNP Paribas Cardif, stands as a formidable entity in India's burgeoning life insurance sector. Born out of a strategic collaboration in 2001, the company has since evolved into one of the top players in the industry, riding on its strong parentage and an extensive distribution network. At its core, SBI Life operates through various channels, including a robust network of individual agents, bancassurance partnerships, and direct sales, allowing it to reach a diverse customer base across urban and rural areas. The company's product portfolio spans traditional policies, unit-linked insurance plans (ULIPs), and various riders, tailored to meet the distinct needs of its clientele, from wealth creation and protection to securing their post-retirement life. The company's revenue model is deeply rooted in the collection of premiums from its policyholders and the prudent investment of these funds. Premiums, both from new and renewal policies, form the primary stream of income, which is then sub-divided into a percentage that covers risk, administrative expenses, and profits. Meanwhile, like most insurance companies, SBI Life accrues substantial investment income from these premiums by channeling funds into a diversified asset portfolio that typically comprises government securities, equities, and bonds. While managing risk is paramount, the company leverages sophisticated actuarial and financial expertise to ensure optimal returns. In essence, SBI Life's financial strength and growth are a testament to its dual focus on securing the trust of its customers through reliable insurance products and continuously enhancing shareholder value through strategic investments.
See Also
What is SBI Life Insurance Company Ltd's Total Equity?
Total Equity
183B
INR
Based on the financial report for Dec 31, 2025, SBI Life Insurance Company Ltd's Total Equity amounts to 183B INR.
What is SBI Life Insurance Company Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
13%
Over the last year, the Total Equity growth was 10%. The average annual Total Equity growth rates for SBI Life Insurance Company Ltd have been 13% over the past three years , 13% over the past five years .